CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 99 filers reported holding CUE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 9.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,200 | -49.6% | 4,000 | -20.0% | 0.01% | -44.4% |
Q2 2023 | $18,250 | +2.2% | 5,000 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $17,850 | -63.2% | 5,000 | -70.6% | 0.01% | -67.9% |
Q4 2022 | $48,450 | +27.5% | 17,000 | 0.0% | 0.03% | +27.3% |
Q3 2022 | $38,000 | +26.7% | 17,000 | +41.7% | 0.02% | +15.8% |
Q2 2022 | $30,000 | +50.0% | 12,000 | +200.0% | 0.02% | +90.0% |
Q1 2022 | $20,000 | -55.6% | 4,000 | 0.0% | 0.01% | -52.4% |
Q4 2021 | $45,000 | -22.4% | 4,000 | 0.0% | 0.02% | -41.7% |
Q3 2021 | $58,000 | +23.4% | 4,000 | 0.0% | 0.04% | +24.1% |
Q2 2021 | $47,000 | -4.1% | 4,000 | 0.0% | 0.03% | -19.4% |
Q1 2021 | $49,000 | -2.0% | 4,000 | 0.0% | 0.04% | -12.2% |
Q4 2020 | $50,000 | -16.7% | 4,000 | 0.0% | 0.04% | -30.5% |
Q3 2020 | $60,000 | – | 4,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |